Advancing Chronic Obstructive Pulmonary Disease Therapy: Opportunities, Challenges, and Excitement
Am J Respir Cell Mol Biol
.
2019 Jan;60(1):1-2.
doi: 10.1165/rcmb.2018-0288ED.
Author
Stephen I Rennard
1
2
Affiliations
1
1 IMED Biotech Unit AstraZeneca Cambridge, United Kingdom and.
2
2 Department of Internal Medicine University of Nebraska Medical Center Omaha, Nebraska.
PMID:
30562048
PMCID:
PMC6835042
DOI:
10.1165/rcmb.2018-0288ED
No abstract available
Publication types
Editorial
MeSH terms
Humans
Prognosis
Pulmonary Disease, Chronic Obstructive / therapy*
Grants and funding
R13 HL142192/HL/NHLBI NIH HHS/United States